225 related articles for article (PubMed ID: 33598674)
1. Stimulation of the Serotonin Receptor 7 Restores Brain Histone H3 Acetylation and MeCP2 Corepressor Protein Levels in a Female Mouse Model of Rett Syndrome.
Napoletani G; Vigli D; Cosentino L; Grieco M; Talamo MC; Lacivita E; Leopoldo M; Laviola G; Fuso A; d'Erme M; De Filippis B
J Neuropathol Exp Neurol; 2021 Feb; 80(3):265-273. PubMed ID: 33598674
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of the brain serotonin receptor 7 rescues mitochondrial dysfunction in female mice from two models of Rett syndrome.
Valenti D; de Bari L; Vigli D; Lacivita E; Leopoldo M; Laviola G; Vacca RA; De Filippis B
Neuropharmacology; 2017 Jul; 121():79-88. PubMed ID: 28419872
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for Rett syndrome.
De Filippis B; Nativio P; Fabbri A; Ricceri L; Adriani W; Lacivita E; Leopoldo M; Passarelli F; Fuso A; Laviola G
Neuropsychopharmacology; 2014 Oct; 39(11):2506-18. PubMed ID: 24809912
[TBL] [Abstract][Full Text] [Related]
4. Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients.
Lilja T; Wallenborg K; Björkman K; Albåge M; Eriksson M; Lagercrantz H; Rohdin M; Hermanson O
Epigenetics; 2013 Mar; 8(3):246-51. PubMed ID: 23348913
[TBL] [Abstract][Full Text] [Related]
5. Dynamic changes in Histone H3 lysine 9 acetylation localization patterns during neuronal maturation require MeCP2.
Thatcher KN; LaSalle JM
Epigenetics; 2006; 1(1):24-31. PubMed ID: 17464364
[TBL] [Abstract][Full Text] [Related]
6. Fluoxetine rescues rotarod motor deficits in Mecp2 heterozygous mouse model of Rett syndrome via brain serotonin.
Villani C; Sacchetti G; Carli M; Invernizzi RW
Neuropharmacology; 2020 Oct; 176():108221. PubMed ID: 32652084
[TBL] [Abstract][Full Text] [Related]
7. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors.
Gold WA; Lacina TA; Cantrill LC; Christodoulou J
J Mol Med (Berl); 2015 Jan; 93(1):63-72. PubMed ID: 25209898
[TBL] [Abstract][Full Text] [Related]
8. MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome.
Wan M; Zhao K; Lee SS; Francke U
Hum Mol Genet; 2001 May; 10(10):1085-92. PubMed ID: 11331619
[TBL] [Abstract][Full Text] [Related]
9. Treatment with the Bacterial Toxin CNF1 Selectively Rescues Cognitive and Brain Mitochondrial Deficits in a Female Mouse Model of Rett Syndrome Carrying a MeCP2-Null Mutation.
Urbinati C; Cosentino L; Germinario EAP; Valenti D; Vigli D; Ricceri L; Laviola G; Fiorentini C; Vacca RA; Fabbri A; De Filippis B
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201747
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine increases brain MeCP2 immuno-positive cells in a female Mecp2 heterozygous mouse model of Rett syndrome through endogenous serotonin.
Villani C; Carli M; Castaldo AM; Sacchetti G; Invernizzi RW
Sci Rep; 2021 Jul; 11(1):14690. PubMed ID: 34282222
[TBL] [Abstract][Full Text] [Related]
11. Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor.
Lyst MJ; Ekiert R; Ebert DH; Merusi C; Nowak J; Selfridge J; Guy J; Kastan NR; Robinson ND; de Lima Alves F; Rappsilber J; Greenberg ME; Bird A
Nat Neurosci; 2013 Jul; 16(7):898-902. PubMed ID: 23770565
[TBL] [Abstract][Full Text] [Related]
12. Histone H3 and H4 modification profiles in a Rett syndrome mouse model.
Urdinguio RG; Pino I; Ropero S; Fraga MF; Esteller M
Epigenetics; 2007; 2(1):11-4. PubMed ID: 17965622
[TBL] [Abstract][Full Text] [Related]
13. 5-HT
Dai H; Kitami Y; Goto YI; Itoh M
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430502
[TBL] [Abstract][Full Text] [Related]
14. Long-lasting beneficial effects of central serotonin receptor 7 stimulation in female mice modeling Rett syndrome.
De Filippis B; Chiodi V; Adriani W; Lacivita E; Mallozzi C; Leopoldo M; Domenici MR; Fuso A; Laviola G
Front Behav Neurosci; 2015; 9():86. PubMed ID: 25926782
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
[TBL] [Abstract][Full Text] [Related]
16. Rett syndrome: a neurological disorder with metabolic components.
Kyle SM; Vashi N; Justice MJ
Open Biol; 2018 Feb; 8(2):. PubMed ID: 29445033
[TBL] [Abstract][Full Text] [Related]
17. Altered somatosensory barrel cortex refinement in the developing brain of Mecp2-null mice.
Moroto M; Nishimura A; Morimoto M; Isoda K; Morita T; Yoshida M; Morioka S; Tozawa T; Hasegawa T; Chiyonobu T; Yoshimoto K; Hosoi H
Brain Res; 2013 Nov; 1537():319-26. PubMed ID: 24060648
[TBL] [Abstract][Full Text] [Related]
18. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3.
Shahbazian M; Young J; Yuva-Paylor L; Spencer C; Antalffy B; Noebels J; Armstrong D; Paylor R; Zoghbi H
Neuron; 2002 Jul; 35(2):243-54. PubMed ID: 12160743
[TBL] [Abstract][Full Text] [Related]
19. Histone modifications in Rett syndrome lymphocytes: a preliminary evaluation.
Kaufmann WE; Jarrar MH; Wang JS; Lee YJ; Reddy S; Bibat G; Naidu S
Brain Dev; 2005 Aug; 27(5):331-9. PubMed ID: 16023547
[TBL] [Abstract][Full Text] [Related]
20. Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome.
Matagne V; Borloz E; Ehinger Y; Saidi L; Villard L; Roux JC
Neurobiol Dis; 2021 Feb; 149():105235. PubMed ID: 33383186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
